Novartis

Novartis Venture Fund is the corporate venture capital division of Novartis, established in 1996 to promote innovation and generate superior returns through strategic investments in innovative life science companies. The fund focuses on the development of new therapeutics, platforms, medical devices, diagnostics, and drug delivery systems. It seeks companies that address unmet medical needs with proprietary technology, strong management, and efficient capital deployment. With over $750 million in committed capital, the fund has a track record of numerous successful exits via IPOs and M&A, and supports companies from early stage through follow-on rounds.